b. hercules2012.igem.org/files/presentation/hkust-hong_kong.pdf · human practice – presentation...
TRANSCRIPT
![Page 1: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/1.jpg)
2012 HKUST iGEM Team
The Terminator of Colon Cancer
B. hercules
![Page 2: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/2.jpg)
Background & Motive
![Page 3: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/3.jpg)
Cancer Therapy & Synthetic Biology
Background & Motive
Our project à Cancer
![Page 4: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/4.jpg)
Represent >90% of colon cancer cases Accessible to agents in gut
Colon Carcinomas – A Suitable Target
Background & Motive
![Page 5: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/5.jpg)
• Non-‐pathogenic.
• Well-‐understood.
• Provide engineering op7ons.
Our Chassis
Background & Motive
• Gut microbiome
• Lacks virulence
• Integrates DNA
Gene integra7on
![Page 6: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/6.jpg)
B. hercules
Background & Motive
Target: colon carcinomas Tool: B. sub'lis
![Page 7: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/7.jpg)
• Target Binding
• An>-‐tumor Molecule Secre>on
• Regula>on & Control
Background & Motive
Three Modules
![Page 8: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/8.jpg)
Module 1
Target Binding
![Page 9: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/9.jpg)
Colon Cancer Cell
Module 1
RPMrel
Tumor Recognition
![Page 10: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/10.jpg)
Bacillus
sub'lis
Module 1
RPMrel
Tumor Recognition
Colon Cancer Cell
![Page 11: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/11.jpg)
LytC
Helical Linker
Module 1
Cell Wall Display
![Page 12: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/12.jpg)
lytC linker RPMrel
Double Terminator
RBS
Pveg
Module 1
Construct
![Page 13: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/13.jpg)
Module 2
Anti-tumor Molecule Secretion
![Page 14: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/14.jpg)
Secrete BMP2 BMP2 Module 2
Anti-tumor Drug
![Page 15: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/15.jpg)
BMP2 Signal pep>de
Module 2
Out
In
Membrane
Secretion
![Page 16: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/16.jpg)
Module 2
Cleavage
Signal pep>de
BMP2
Secretion
![Page 17: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/17.jpg)
SPPase
BMP2 Folding
Module 2
Secretion
![Page 18: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/18.jpg)
RBS xylR Bmp2 Signal pep>de
PxylA
Module 2
Construct
![Page 19: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/19.jpg)
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
0.0001 0.001 0.01 0.1
Percen
tage of V
iable Ce
lls
B. sub'lis Concentra>on (OD650)
Viability of HT-‐29 Cells Following Co-‐Culture with B. sub'lis
B. sub7lis transformed with empty vector B. sub7lis transformed to express BMP2
Module 2
BMP2 Functional Assay
B. sub'lis B. sub'lis
![Page 20: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/20.jpg)
Regulation & Control
Module 3
![Page 21: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/21.jpg)
Two Regula>on Systems
1. Time Control 2. Dosage Regula>on
Module 3
Regulation Systems
![Page 22: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/22.jpg)
RBS xylR
PxylA
Module 3
Xylose-Inducible Promoter
![Page 23: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/23.jpg)
RBS xylR Bmp2 Signal pep>de
PxylA
XylR Inhibited Transcrip>on
Module 3
Xylose-Inducible Promoter
![Page 24: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/24.jpg)
RBS xylR Bmp2 Signal pep>de
PxylA
XylR Transcrip>on Proceeds
Module 3
xylose
Xylose-Inducible Promoter
![Page 25: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/25.jpg)
Bmp2 Signal
pep>de
ydcE RBS
An>toxin Toxin
EndoA EndoAI
Module 3
Growth Inhibition Device
![Page 26: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/26.jpg)
Bacillus sub'lis
Growth Inhibi>on
EndoA
(Toxin)
EndoAI
(An>toxin)
Module 3
Growth Inhibition Device
![Page 27: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/27.jpg)
OD (Average OD595)
Module 3
RBS
Promoter Ac>vity =
Ptms GFP RBS
Double terminator
J23101 GFP
GFP Synthesis Rate (Slope)
Promoter Ac>vity of Ptms
Promoter Ac>vity of Standard Promoter
Rela>ve Promoter Unit (RPU) of Ptms to reference standard promoter =
Double terminator
Ptms Characterization
![Page 28: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/28.jpg)
y = 3.4x + 3.8
y = 35.45x + 225.7
0
50
100
150
200
250
300
350
400
450
0 15 30 45 60
GFP Intensity
(Arbitrary Units)
Time (minutes)
Ptms & J23101 GFP Intensity Ptms J23101
Module 3
Ptms
Ptms has Low Activity
RPU: 0.046
![Page 29: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/29.jpg)
0
50
100
150
200
250
300
350
0% 1% 2% 3% 4% 5% 10%
GFP Synthe
sis R
ate/Av
erage OD5
95
Xylose Concentra>on
PxylA Promoter Ac>vity Induced With 0-‐10% Xylose
Module 3
PxylA is Inducible
![Page 30: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/30.jpg)
Control Group Experiment Group
Xylose concentra'on from le6 to right (both groups): 0.00%, 0.05%, 0.10%, 0.15%, 0.20%, 0.25%
Module 3
Growth Inhibition Characterization
![Page 31: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/31.jpg)
Assembly
![Page 32: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/32.jpg)
Assembly
Three Modules
• Target Binding
• An>-‐tumor Molecule Secre>on
• Regula>on & Control
![Page 33: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/33.jpg)
Assembly
Modules Assembled
Bacterial Chromosome
amyE 3’ amyE 5’ RPMrel
Expression
xylR
PxylA BMP2 Secre>on Toxin An>-‐
toxin
RPMrel
LytC
EndoA EndoAI
Ptms
![Page 34: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/34.jpg)
Achievements & Future Work
![Page 35: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/35.jpg)
• PxylA, Ptms func>on as expected. • Cell growth inhibi>on device func>ons. • RPMrel produc>on – work in progress. • BMP2 produc>on – work in progress.
Achievements & Future Work
Our Work
![Page 36: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/36.jpg)
Human Practice
![Page 37: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/37.jpg)
Presenta>on at Hong Kong Cancer Fund
Human Practice – Presentation
Presentation
![Page 38: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/38.jpg)
Human Practice – Presentation
Objective & Role
![Page 39: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/39.jpg)
Human Practice – Presentation
Presentation
![Page 40: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/40.jpg)
Human Practice – Presentation
Positive Feedback
Synthe'c biology can be used to improve cancer treatment. -‐-‐-‐ Respondent A
Synthe'c biology will give cancer pa'ents hope. -‐-‐-‐ Respondent B
This presenta'on is clear and professional. -‐-‐-‐ Respondent C
Some of the seeds have [been] planted which will allow us to keep a close eye to its (synthe'c biology’s) development.
-‐-‐-‐ Ms. HSUEH, the Head of Wellness and Holis7c Health Care
![Page 41: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/41.jpg)
Human Practice – Interviews
Interviews
![Page 42: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/42.jpg)
POLITICIAN JOURNALIST
UNIVERSITY STUDENT HIGH SCHOOL STUDENT
Human Practice – Interviews
Interviews
![Page 43: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/43.jpg)
Human Practice – Interviews
Interviews
…I will listen to their complaints sincerely as a responsible listener… …I will tell them how to raise this issue to higher authority… …But the final decision should be made only by the majority…
-‐-‐-‐ The poli7cian, Mr. SHUM
![Page 44: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/44.jpg)
Human Practice – Interviews
Interviews
• Gather informa7on about the interviewees.
• Generate an interview outline and ques7ons specific targe7ng at the interviewee.
• Guide your interviewers and train them to good interviewers.
![Page 45: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/45.jpg)
Human Practice
Human Prac>ce
Presenta>on Interviews
![Page 46: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/46.jpg)
Recap
![Page 47: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/47.jpg)
Cell growth inhibi7on
Toxin-‐an7toxin casse_e
Colon tumor growth
suppression
Chemokine expression
Tumor targe7ng
Pep7de display
B. sub'lis
Recap
Integrated Genes
![Page 48: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/48.jpg)
• Office of the Dean of Science
• Office of the Provost
– The Hong Kong University of Science & Technology
Acknowledgements
![Page 49: B. hercules2012.igem.org/files/presentation/HKUST-Hong_Kong.pdf · Human Practice – Presentation Presentation . Human Practice – Presentation Objective & Role . Human Practice](https://reader033.vdocuments.site/reader033/viewer/2022050521/5fa4337dd0475572260f8b6d/html5/thumbnails/49.jpg)
2012 HKUST iGEM Team
The Terminator of Colon Cancer
B. hercules